We are live on ! Find out more
AWGLSCP

ABG-WTT Global Life Science Capital Partners Portfolio holdings

AUM $8.55M
1-Year Est. Return 12.76%
This Fund
S&P 500
This Quarter Est. Return
-5.07%
1 Year Est. Return
-12.76%
3 Year Est. Return
+124.51%
5 Year Est. Return
-90.22%
10 Year Est. Return
–
AUM
$8.55M
AUM Growth
-$3.74M
Cap. Flow
-$3.16M
Cap. Flow %
-36.95%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CBLL
CeriBell Inc
CBLL
+$3.16M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBLL
1
CeriBell Inc
CBLL
$907M
$5.36M 62.61%
275,328
-166,492
-38% -$3.16M
RPID icon
2
Rapid Micro Biosystems
RPID
$61.7M
$3.2M 37.39%
1,848,296
– –

Similar funds

BFG
Brandywine Financial Group Thompsons Station, Tennessee $8.39M AUM
CCP
Caden Capital Partners Santa Monica, California $8.3M AUM 30.73% 1-Year Est. Return
VH
Vitol Holding Rotterdam, Netherlands $8.83M AUM 12.58% 1-Year Est. Return
RG
Raine Group New York $8.86M AUM 15.08% 1-Year Est. Return
GDADCM
Groupe des Assurances du Credit Mutuel Strasbourg, France $8.04M AUM 18.77% 1-Year Est. Return
GMP
Great Mountain Partners New Haven, Connecticut $9.28M AUM 89.06% 1-Year Est. Return
FRT
FTX Recovery Trust League City, Texas $9.43M AUM
AIA
Acute Investment Advisory Mesa, Arizona $9.46M AUM 13.58% 1-Year Est. Return

ABG-WTT Global Life Science Capital Partners's Q2 2026 Portfolio in Review

As of Q2 2026, ABG-WTT Global Life Science Capital Partners held 2 positions worth $8.55M, down 30% from $12.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ABG-WTT Global Life Science Capital Partners withdrew a net $3.16M in Q2 2026, reducing 1 holding. Its largest reduction was CeriBell Inc, cutting an estimated $3.16M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ABG-WTT Global Life Science Capital Partners's biggest Q2 2026 reduction was CeriBell Inc, cutting an estimated $3.16M.
  • ABG-WTT Global Life Science Capital Partners's ten largest holdings make up 100% of its $8.55M portfolio in Q2 2026.
  • ABG-WTT Global Life Science Capital Partners opened 0 new positions and closed 0 in Q2 2026.
  • ABG-WTT Global Life Science Capital Partners's portfolio value fell 30% quarter-over-quarter to $8.55M.

Based on ABG-WTT Global Life Science Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.